Sentara Lawsuit: Whistleblower, HIPAA, and Antitrust Cases

Sentara Health, one of the Mid-Atlantic’s largest not-for-profit health systems, has been the target of a range of significant lawsuits and federal enforcement actions. Anyone researching a Sentara lawsuit is likely looking at one of several distinct matters: a federal False Claims Act whistleblower case over Affordable Care Act premiums, a recently settled retirement-plan class action, an active wage and hour suit, a medical malpractice claim, earlier settlements involving cardiac device billing and HIPAA violations, and competitor complaints about the system’s market power in Virginia. Several of these cases are still moving.

The ACA Whistleblower Case

The largest ongoing matter is a qui tam suit filed in 2020 by three Charlottesville-area residents — Ian Dixon, Karl Quist, and Sara Stovall — none of whom worked for Sentara. The complaint names Sentara, its insurance arm (then Optima Health, now Sentara Health Plans), and the actuarial firm Milliman, and alleges violations of the federal False Claims Act tied to premiums on the ACA marketplace in the Charlottesville region for 2018 and 2019, where Optima was the sole individual-market insurer.¹

What the Suit Alleges

At the core is a pricing metric called the Area Rate Factor. The complaint says Optima applied an ARF of 1.579 to its ACA individual plans while using a factor of 0.93 for its small-group plans in the same region, served by the same providers. The whistleblowers argue that gap points to deliberate rate manipulation rather than legitimate actuarial work. They also allege Milliman’s health cost guidelines reflected geographic differences in morbidity, a factor the ACA prohibits in premium calculations, and that federal certification language for Optima’s 2018 rates was altered to obscure this.²

The complaint describes the alleged overcharges as “knowingly fraudulent surcharges” that produced “massive illicit profits” and inflated the federal ACA subsidies Sentara collected. The whistleblowers say the government was defrauded of $665 million in subsidies and are seeking more than $200 million in damages and civil penalties.³⁴

DOJ Involvement and Withdrawal

The Justice Department was engaged for years. In November 2023, DOJ filed a petition in U.S. District Court in Charlottesville alleging Sentara had withheld documents from investigators. In December 2024, the government notified the court it intended to intervene. Then, on June 19, 2025, DOJ withdrew that notice and declined to participate further. The government had already declined to intervene against Milliman on the claims tied solely to its actuarial guidelines.⁴¹

DOJ still retains oversight rights. The whistleblowers cannot dismiss or settle the case without the Attorney General’s written consent, but the government is no longer actively litigating. On July 2, 2025, the court ordered the whistleblowers to file an amended complaint within 60 days and to serve it on defendants within 21 days after that. Legal observers noted that without DOJ backing, the plaintiffs likely will not have access to the evidence the government gathered during its own investigation.⁴

Sentara has consistently called the claims “meritless.” It says its 2017 rate formulations were based on “sound actuarial principles,” approved by state regulators, and compliant with all applicable laws, and that it issued over $98 million in rebates to Virginia policyholders for the 2018 plan year under ACA regulations.⁵

Retirement Plan Class Action Settled for $1.5 Million

In January 2025, two Sentara plan participants, Tracey Carter and Bonny Davis, filed a proposed class action in the U.S. District Court for the Eastern District of Virginia. The case, Carter et al. v. Sentara Healthcare Fiduciary Committee et al., targeted a stable value fund offered through a Guaranteed Interest Balance Contract from Principal Life Insurance Co.⁶

The plaintiffs said the Principal product was an “off-the-shelf” investment with “uncompetitive returns” that lagged inflation and comparable funds by one to two percentage points annually since 2019, producing more than $11.4 million in losses through 2023. The plan held roughly $136 million in the fund at year-end 2023, which the plaintiffs argued gave Sentara substantial bargaining power that the fiduciary committee did not use, allegedly never soliciting competing proposals.⁶

Judge Jamar K. Walker denied Sentara’s motion for summary judgment on January 30, 2026, finding that although Sentara followed a “generally prudent process,” including hiring an outside investment consultant and holding quarterly reviews, a trial was still needed on whether the fund was properly monitored.⁷ The parties reached a $1.5 million settlement on April 1, 2026, before trial.⁸

Wage and Hour Class and Collective Action

On April 8, 2025, former respiratory therapist and administrative associate Jasmine Ward filed a class and collective action against Sentara Hospitals alleging systematic wage theft. Ward worked at Sentara’s Albemarle Medical Facility, Norfolk General Hospital, and Obici Hospital from roughly October 2021 to February 2025 and alleged violations of the Virginia Overtime Wage Act, the Virginia Wage Payment Act, and the federal Fair Labor Standards Act.⁹

The suit challenges two payroll practices. First, it alleges Sentara automatically deducted 30 minutes for meal periods even when employees worked through them or were interrupted. Second, it alleges Sentara rounded clock-in and clock-out times to the nearest quarter hour and barred employees from punching in or out more than 7.5 minutes before or after a shift, effectively shaving paid time. Ward seeks unpaid wages, overtime compensation, liquidated and treble damages, and a jury trial on behalf of similarly situated patient-care employees. Sentara said it was “unable to comment on the specifics” but stated that “Sentara policies comply with all wage and hour laws.”⁹

Retained Surgical Sponge Malpractice Suit

In early 2026, a South Carolina mother filed a medical malpractice lawsuit against Sentara in Norfolk, alleging a surgical sponge was left inside her body after childbirth at Sentara Leigh Hospital. The complaint says the retained sponge caused an infection and required an additional procedure to remove. The plaintiff seeks approximately $836,000 in damages. A Sentara spokesperson said in April 2026 the organization had not yet been formally served.¹⁰

Earlier Federal Settlements

Cardiac Defibrillator Billing (2016)

In 2016, Sentara paid $2.1 million to resolve a DOJ civil investigation alleging four of its hospitals — Sentara Heart Hospital and Sentara Leigh in Norfolk, Sentara Obici in Suffolk, and Sentara Virginia Beach General — implanted cardiac defibrillators in violation of Medicare coverage rules. Federal rules set in 2003 require a 40-day wait after a heart attack and a 90-day wait after bypass surgery or angioplasty before an implantable defibrillator can be billed to Medicare, so the heart has time to recover.¹¹

The case grew out of a 2008 whistleblower complaint filed in Kentucky and was part of a broader federal enforcement effort that produced over $250 million in settlements with 457 hospitals nationwide. As part of the resolution, Sentara put in place new processes so Medicare would not be billed when the coverage timeframe requirements were not met, while leaving implant decisions to clinical judgment.¹¹

HIPAA Privacy Settlement (2019)

In November 2019, Sentara Hospitals agreed to pay $2.175 million to the Department of Health and Human Services Office for Civil Rights over violations of the HIPAA Privacy and Breach Notification Rules. Billing information for 577 patients — names, account numbers, and dates of service — was sent to the wrong addresses after being merged with mailing labels for more than 16,000 other individuals.¹²

Much of the penalty stemmed from the response, not the mailing error itself. Sentara reported only eight affected individuals to OCR, taking the position that because no diagnosis or treatment information was disclosed, the incident did not qualify as a reportable breach. OCR advised Sentara that all 577 individuals were affected and required notification, but Sentara refused to update its report. OCR also found Sentara Hospitals had operated without a required business associate agreement with its parent, Sentara Healthcare, until October 2018. The settlement carried a two-year compliance monitoring period.¹³

Antitrust and Market-Dominance Complaints

Sentara has also drawn recurring complaints about its market position. It holds over 72% of inpatient market share in Hampton Roads and fully owns Sentara Health Plans (formerly Optima), which merged with Virginia Premier in July 2023 to become Virginia’s largest Medicaid insurer at roughly 34% of the statewide market.¹⁴¹⁵

In May 2021, Anthem sent a letter to then-Attorney General Mark Herring asking for an investigation into what it called Sentara’s “monopoly status” and efforts to “limit payor competition.” The letter followed Sentara’s April 2021 notice that it intended to terminate its Medicare and Medicaid contracts with Anthem, a move that would have affected about 525,000 patients. Sentara rescinded the notice in August 2021 after negotiations. The Attorney General’s office did not confirm or deny whether an investigation was opened.¹⁵

That same spring, Chesapeake Regional Medical Center filed a $20 million suit against Sentara Medical Group in Chesapeake Circuit Court, alleging Sentara had worked to “aggressively and intentionally cripple” its cardiology program. The complaint said Sentara held secret meetings with seven cardiologists under contract with a group staffing Chesapeake Regional, recruited them to break their contracts, and used its influence in the state’s Certificate of Public Need process to block Chesapeake Regional’s application for an open-heart surgery program. Sentara held roughly 70% of the regional cardiology market at the time.¹⁶¹⁷

A 2023 report by the Virginia Joint Commission on Health Care examined the broader competitive implications of vertically integrated health systems like Sentara, including concerns that such carriers could sidestep Medical Loss Ratio profit caps by making inflated payments to their own affiliated hospitals, keeping money inside the system rather than refunding members or the state.¹⁴

1
Virginia Business. Whistleblowers in Sentara Insurance Investigation Revealed
2
Virginia Business. The Rate Stuff
3
C-Ville Weekly. Whistleblower Suit Against Sentara Takes New Twist
4
Virginia Business. DOJ Withdraws From Sentara Investigation
5
Sentara Health. DOJ Investigation
6
PLANSPONSOR. Sentara Healthcare Sued Over Underperforming Stable Value Investment Option
7
Bloomberg Law. Sentara Health Retirement Fund Class Suit Advances Toward Trial
8
Law360. Sentara Health Strikes $1.5M Deal in Stable Value Fund Suit
9
WTKR. Former Sentara Employee Files Lawsuit Over Alleged Unpaid Wages
10
Yahoo News. South Carolina Mother Sues Sentara
11
The Virginian-Pilot. Sentara Settles Lawsuit Over Allegations About Cardiac Devices
12
Fierce Healthcare. Sentara Hospitals to Pay $2.2M HIPAA Settlement for Undisclosed Data Breaches
13
HIPAA Journal. $2.175 HIPAA Settlement Agreed With Sentara Hospitals
14
Virginia Joint Commission on Health Care. Vertically Integrated Carriers and Providers Final Report
15
News From the States. Virginia’s Largest Insurer Wants Investigation Into Sentara Anti-Competitive Harm
16
WAVY. Chesapeake Regional Files $20M Lawsuit Against Sentara Over Cardiologists, Open Heart Program
17
Virginia Mercury. Two Hampton Roads Health Systems Are Caught in a Legal Battle